Related Experiment Video
Updated: May 14, 2026

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes
Published on: September 28, 2018
The insulin receptor negatively regulates the action of Pseudomonas toxin-based immunotoxins and native Pseudomonas
Xiu Fen Liu1, David J FitzGerald, Ira Pastan
1Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Abstract:
SS1P is a recombinant immunotoxin composed of an antimesothelin Fv fragment fused to a truncated portion of Pseudomonas exotoxin A. SS1P targets and kills mesothelin-expressing tumors, which include mesothlioma as well as ovarian, lung, and pancreatic cancers. SS1P is currently in clinical trials in mesothelioma. Because insulin acting through the insulin receptor is a survival factor for many cancer cell lines, we explored how lowering insulin receptor level would affect the cytotoxic action of SS1P. We show here that siRNA knockdown of the insulin receptor enhanced the cytotoxic action of native Pseudomonas exotoxin and enhanced SS1P toxicity on several human cell lines, but did not affect the response to other cytotoxic agents such as TRAIL, etoposide, and cycloheximide. To determine how insulin receptor knockdown enhances SS1P action, we analyzed various steps involved in cell killing. We found that insulin receptor knockdown increases the cleavage of SS1P by furin, which allows more toxin to reach the cytosol and inactivate elongation factor 2. These findings indicate that the insulin receptor negatively regulates immunotoxin action.
Insights
Lowering insulin receptor levels boosts the effectiveness of SS1P immunotoxin against cancers like mesothelioma. This occurs because reduced insulin receptor levels enhance SS1P
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- SS1P is an antimesothelin immunotoxin targeting mesothelin-expressing tumors.
- Mesothelin is found in mesothelioma, ovarian, lung, and pancreatic cancers.
- Insulin receptor signaling is a known survival factor for cancer cells.
Purpose of the Study:
- To investigate the effect of reducing insulin receptor levels on SS1P immunotoxin efficacy.
- To determine the mechanism by which insulin receptor levels influence SS1P's cytotoxic action.
Main Methods:
- Utilized siRNA to knock down insulin receptor expression in human cancer cell lines.
- Assessed the cytotoxicity of SS1P and other agents (Pseudomonas exotoxin A, TRAIL, etoposide, cycloheximide) after insulin receptor knockdown.
- Analyzed SS1P cleavage by furin and its subsequent effect on elongation factor 2.
Main Results:
- siRNA-mediated insulin receptor knockdown significantly enhanced SS1P toxicity in multiple cell lines.
- Knockdown also increased the cytotoxicity of native Pseudomonas exotoxin A.
- The enhancement was specific to SS1P and Pseudomonas exotoxin A, not affecting responses to TRAIL, etoposide, or cycloheximide.
- Insulin receptor knockdown increased SS1P cleavage by furin, leading to greater elongation factor 2 inactivation.
Conclusions:
- The insulin receptor negatively regulates the cytotoxic action of SS1P immunotoxin.
- Targeting the insulin receptor may represent a strategy to improve SS1P efficacy in treating mesothelin-expressing cancers.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
The JAK-STAT Signaling Pathway
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Gene Regulation in Microbial Communities: Quorum Sensing
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...

